These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 5040933

  • 1. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
    Nahas A, Friedkin M.
    Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Mathematical description and study of the folic acid cycle reactions].
    Vorontsov IN, Greshilov MM, Belousova AK, Gerasimova GK.
    Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of pretreatment with methotrexate on the reduction of dihydrohomofolic acid in mice.
    Mishra LC, Parmar AS, Mead JA.
    Biochem Pharmacol; 1971 Oct; 20(10):2871-8. PubMed ID: 5114519
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 7,8-Dihydropteroyl oligo-gamma-L-glutamates: synthesis and kinetic studies with purified dihydrofolate reductase from mammalian sources.
    Coward JK, Parameswaran KN, Cashmore AR, Bertino JR.
    Biochemistry; 1974 Sep 10; 13(19):3899-903. PubMed ID: 4528865
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation].
    Belousova AK, Gerasimova GK, Vorontsov IN, Greshilov MM.
    Biokhimiia; 1980 Apr 10; 45(4):609-21. PubMed ID: 6769505
    [Abstract] [Full Text] [Related]

  • 14. The use of dihydrofolate reductase as a signal for scheduling optimal treatment with antileukemic agents.
    Hardesty CT, Chen D, Mead JA.
    Cancer Res; 1972 Mar 10; 32(3):458-61. PubMed ID: 5061301
    [No Abstract] [Full Text] [Related]

  • 15. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC, Fan CC, Howell SB.
    J Natl Cancer Inst; 1981 Jan 10; 66(1):121-4. PubMed ID: 6935452
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M.
    Acta Biochim Pol; 1988 Jan 10; 35(3):199-205. PubMed ID: 2469275
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.